This is a routine tax-withholding sale with no discretionary insider intent. No bearish read-through. Monitor for any subsequent discretionary insider sales or material corporate events.
Price Chart
Executive Summary
Sumita Ray, Corporate Secretary of Cue Biopharma, filed a Form 144 to sell 8,829 shares of common stock valued at approximately $266,106. The sale is a mandatory 'sell to cover' transaction to satisfy tax withholding obligations upon vesting of restricted stock units, not a discretionary insider sale. This is a routine, non-discretionary filing with no bearish signal for the stock.
Key Facts
- Sumita Ray (Corporate Secretary) filed Form 144 to sell 8,829 shares.
- Estimated proceeds: ~$266,106 based on ~$30.14/share.
- Sale is mandatory 'sell to cover' for tax withholding on RSU vesting, not discretionary.
- Broker: Maxim Group LLC.
- Filing date: August 13, 2026.
Financial Impact
~$266,106 in proceeds from 8,829 shares sold at estimated ~$30.14/share.
Risk Factors
- No material risk identified from this filing; the sale is mandatory and non-discretionary.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001579629-26-000006 |
| Document: 0001579629-26-000006-index.html | 0001579629-26-000006 |
| Document: 0001579629-26-000006.txt | 0001579629-26-000006 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | Insider Cluster | $18.67 $16.71 | ▲ +10.50% | ▲ +9.39% | $18.45 (+1.18%) |
Oct 13, 2026 13d ago | 144 | $18.60 $18.67 | ▲ +0.38% | ▲ +0.09% | $18.45 (−0.81%) |
Oct 8, 2026 18d ago | SC 13G/A | $22.33 $27.66 | ▲ +23.87% | ▲ +23.27% | $18.45 (−17.38%) |
Sep 21, 2026 5w ago | 8-K | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.45 (−34.74%) |
Sep 20, 2026 5w ago | Press Release | $28.27 $30.90 | ▲ +9.30% | ▲ +9.32% | $18.45 (−34.74%) |
Aug 21, 2026 9w ago | EFFECT | $23.98 $23.18 | ▲ +3.34% | ▲ +3.04% | $18.45 (+23.06%) |
Aug 17, 2026 10w ago | Insider Cluster | $25.70 $26.28 | ▼ −2.26% | ▼ −2.05% | $18.45 (+28.21%) |
Aug 14, 2026 10w ago | Press Release | $27.64 $25.70 | ▼ −7.02% | ▼ −6.34% | $18.45 (−33.25%) |
Aug 13, 2026 10w ago | 144 | $34.20 $27.64 | ▼ −19.18% | ▼ −18.71% | $18.45 (−46.05%) |
Jul 9, 2026 15w ago | Press Release | $36.78 $30.92 | ▼ −15.93% | ▼ −15.17% | $18.45 (−49.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers